TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/22/2022
Back to search
Official data from USPTO
THE ONCOLOGIST CLINICAL TRIAL RESULTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
04/22/2022
Trademark type
Combined
Nice classes
42
Filing date
11/25/2020
Registration date
09/14/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2021
Last transaction
04/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2012-05-00
First use in commerce
2012-05-00
Drawing code
3
Owner type
03
Owner location
Durham, NC
Examiner
RIEPEL, CHRISTINA
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a flower design followed by the "THE ONCOLOGIST" over the words "CLINICAL TRIAL RESULTS".
Holders and representatives
Holders
The AlphaMed Company, Inc.
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Representatives
Mark Lerner, Esq. DUANE MORRIS LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical research and scientific research information in the nature of clinical trial results in the field of oncology via the internet; providing a website featuring technology for collecting clinical trial results in the field of oncology via the internet for use in an online and printed journal
Publications
History of USPTO decisions and trademark events.
20 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/14/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/29/2021
PUBO
PUBLISHED FOR OPPOSITION
06/29/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/26/2021
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/20/2021
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/20/2021
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
05/20/2021
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/20/2021
DOCK
ASSIGNED TO EXAMINER
05/11/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/30/2021
NWAP
NEW APPLICATION ENTERED
11/28/2020
Continuous trademark protection
Get notified about every new filing that threatens THE ONCOLOGIST CLINICAL TRIAL RESULTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.